Use of Intralesional and Perilesional Human Recombinant Epidermal Growth Factor (hrEGF) in the Local Treatment of Venous Ulcer – Review Article – Expert Recommendation

Venous Ulcers (VU) represent 60–80% of all leg ulcers and are the final stage of the disease secondary to venous hypertension or valve insufficiency. Conventional treatment that focuses on its etiological factors continues to be the gold standard; however, 30% of ulcers do not heal with this treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacua Sanchez, Maria Teresa, Vargas Abello, Lina M, Orrego, Álvaro, Ortiz, Paola, Segura, Héctor, Berrio Caicedo, Jhon Jairo, Zuluaga, Luz Marina, Ordoñez, José, Fernández Montequin, José Ignacio, Ulloa, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494861/
https://www.ncbi.nlm.nih.gov/pubmed/37701155
http://dx.doi.org/10.2147/VHRM.S417447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494861/
https://www.ncbi.nlm.nih.gov/pubmed/37701155
http://dx.doi.org/10.2147/VHRM.S417447

Ejemplares similares